Keystone Financial Group
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1729299
LEXINGTON, KY
Position in ARWR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$501,600
-$29,520 QoQ
Shares Held
8,000
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Keystone Financial Group holds $1,451,239 across 7 Biotechnology names. ARWR ranks #2 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRME |
Prime Medicine, Inc.
|
166,010 | $577,714 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
8,000 | $501,600 | |
| 3 | CRBU |
Caribou Biosciences, Inc.
|
80,475 | $152,902 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
10,000 | $76,700 | |
| 5 | LRMR |
Larimar Therapeutics, Inc.
|
13,000 | $58,500 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
16,000 | $49,120 | |
| 7 | EDIT |
Editas Medicine, Inc.
|
14,050 | $34,703 |
All Filings in ARWR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $501,600 | 8,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $531,120 | 8,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $275,920 | 8,000 | Shares | Sole | 2025-11-17 | |
| 2024-06-30 | $207,920 | 8,000 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $228,800 | 8,000 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $244,800 | 8,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $214,960 | 8,000 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $338,770 | 9,500 | Shares | Sole | 2023-08-07 | |
| 2022-12-31 | $385,320 | 9,500 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $256,137 | 7,750 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $264,075 | 7,500 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $275,940 | 6,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $397,800 | 6,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $374,580 | 6,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $314,716 | 3,800 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $251,978 | 3,800 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $291,574 | 3,800 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||